Amneal Pharmaceuticals, Inc. is a publicly listed company traded on the New York Stock Exchange (NYSE: AMRX). It is the result of the merger between Amneal Pharmaceuticals and Impax Laboratories, which took place on May 4, 2018. Under the new corporate parent, Amneal Pharmaceuticals operates as a leading pharmaceutical company based in Hayward, CA.
Amneal Pharmaceuticals offers a wide range of products, including those from Impax and Gemini Laboratories. With a focus on quality and safety, the company encourages customers to report any adverse events or product quality complaints in the United States through their dedicated channels. As a trusted name in the industry, Amneal Pharmaceuticals strives to provide reliable medical information and exceptional pharmaceutical products to its customers.
Generated from the website